Rockwell Medical, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 09 2021 - 9:52AM
Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company
dedicated to transforming the treatment of iron deficiency and
anemia management and improving outcomes for patients around the
world, today announced that members of its executive management
team are scheduled to present at the H.C. Wainwright 23rd Annual
Global Investment Conference, being held virtually September 13-15,
2021.
The presentation will become publicly available
for on-demand listening beginning on Monday, September 13 at 7:00
a.m. Eastern Time in the “Investors” section of the Company’s
website at www.rockwellmed.com. A replay of the webcast will be
archived on the Company’s website for 30 days.
In addition to the presentation, management will
be available to participate in virtual one-on-one meetings with
qualified members of the investor community who are registered to
attend the conference. For more information about the conference,
please visit the conference website.
About Rockwell Medical
Rockwell Medical is a commercial-stage biopharmaceutical company
developing and commercializing its next-generation parenteral iron
technology platform, Ferric Pyrophosphate Citrate (FPC), which has
the potential to lead transformative treatments for iron deficiency
in multiple disease states, reduce healthcare costs and improve
patients’ lives. The Company has two FDA-approved therapies
indicated for patients undergoing hemodialysis, which are the first
two products developed from the FPC platform. The Company is
developing FPC for the treatment of iron deficiency in patients
outside of dialysis, who are receiving intravenous medications in
the home infusion setting, a large and rapidly growing segment of
healthcare, and where these patients suffer from chronic diseases
associated with high incidence of iron deficiency and anemia. In
addition, Rockwell Medical is one of two major suppliers of
life-saving hemodialysis concentrate products to kidney dialysis
clinics in the United States. For more information, visit
www.rockwellmed.com.
CONTACTS
Investors:Argot
Partners212.600.1902Rockwell@argotpartners.com
Media:David RosenArgot
Partners212.600.1902david.rosen@argotpartners.com
Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart
From Apr 2023 to Apr 2024